Tabula Rasa HealthCare and Medplus Solutions form Partnership to Bring MedWise™ Medication Safety Solutions to Puerto Rico
Tabula Rasa HealthCare (TRHC) announced a partnership with Medplus Solutions, a pharmacy services provider in Puerto Rico, to implement MedWise medication safety solutions for long-term care clients. This collaboration aims to enhance clinical pharmacy services and mitigate medication risks for patients on multiple medications.
MedWise uses the MedWise Risk Score (MRS) to identify potential adverse drug events. A published study showed that reducing the MRS leads to fewer emergency visits and lower medical costs. Medplus serves more than 500 facilities, catering to approximately 10,000 patients.
- Partnership with Medplus Solutions to deploy MedWise solutions improves medication safety for long-term care patients.
- MedWise technology predicted to reduce adverse drug events and hospitalizations, potentially lowering healthcare costs.
- None.
MOORESTOWN, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today that Medplus Solutions, a pharmacy services provider in Puerto Rico, will deploy MedWise™ medication safety solutions for their long-term care clients. Additionally, Medplus will enhance their clinical pharmacy services by certifying their pharmacists as MedWise Advisors™.
"As the only dedicated and accredited long-term care pharmacy in Puerto Rico, we understand how vital medication safety is for chronically-ill patients on multiple medications,” states Sultan S. Yassin, PharmD, President and CEO of Medplus. “MedWise will allow us to identify simultaneous multi-drug interactions and will facilitate interventions by our pharmacists to those most at risk for adverse drug events. Our goal is to keep our patients safer and healthier.”
TRHC’s MedWise software provides science-based, actionable clinical intelligence to pharmacists, including assessing a patient’s MedWise Risk Score™ (MRS). The MRS calculation uses active medication ingredients of a patient’s complete medication list, including over-the-counter supplements to predict the risk of adverse drug events (ADEs). A published study, involving nearly 2,000 patients, found that a reduction in the MRS resulted in fewer adverse drug events, emergency department visits, and hospitalizations and lower medical costs.
“Managing patients with chronic conditions and on multiple medications requires a coordinated clinical pharmacy approach to medication management,” states TRHC Chairman and CEO Calvin H. Knowlton, PhD. “By deploying TRHC’s MedWise solution and providing MedWise Advisor certification for its pharmacists, Medplus will bring enhanced clinical services and improved medication outcomes to Puerto Rico.”
Puerto Rico has approximately 25,000 licensed assisted living, nursing home, and mental health beds. Medplus Solutions provides services to more than 500 facilities and 10,000 beds.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, pharmacist providers and other healthcare organizations. For more information, visit TRHC.com.
About Medplus Solutions
Medplus Solutions is a leading provider of innovative medication and population management services that help long term care facilities, employer groups and health plans improve quality of care and reduce healthcare costs. Medplus is the only provider in Puerto Rico accredited by the prestigious Accreditation Commission for Health Care (ACHC) to provide long-term care pharmacy, specialty pharmacy and compounding pharmacy services.
Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
| TRHC Media Contact Amanda Bednar abednar@trhc.com T: (856) 912-5714 Dianne Semingson dsemingson@trhc.com T: (215) 870-0829 | TRHC Investor Contact Frank Sparacino fsparacino@trhc.com T: (866) 648-2767 |
FAQ
What is the partnership between Tabula Rasa HealthCare and Medplus Solutions?
How does MedWise improve medication safety for patients?
What is the MedWise Risk Score (MRS)?
What benefits does the partnership offer to Medplus Solutions?
